Adial Pharmaceuticals, Inc.
ADIL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001513525
In the last 90 days, Adial Pharmaceuticals, Inc. insiders filed 2 open-market purchases and 0 sales; 17 institutions reported holding it in 13F filings for Q2 2026, worth $334.6K in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Adial Pharmaceuticals, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 26 | 28 | +2 |
| Shares | 1.70M | 1.99M | +292.6K (+17.3%) |
| Value | $2.27M | $692.1K | −$1.58M (−69.6%) |
New holders (7)
Institutions that held Adial Pharmaceuticals, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 265,062 | $93.0K | 0.00% |
| Two Sigma Investments, LP | 58,389 | $20.0K | 0.00% |
| UBS Group AG | 35,517 | $12.0K | 0.00% |
| Two Sigma Securities, LLC | 17,802 | $6.00K | 0.00% |
| American Portfolios Advisors | 5,500 | $1.93K | 0.00% |
| FMR LLC | 7 | $0 | 0.00% |
| Royal Bank of Canada | 25 | $0 | 0.00% |
Sold out (5)
Institutions that held Adial Pharmaceuticals, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Susquehanna International Group, LLP | 99,103 | $133.0K |
| Millennium Management LLC | 39,490 | $53.0K |
| Charles Schwab Investment Management Inc | 21,443 | $29.0K |
| Jane Street Group, LLC | 13,854 | $19.0K |
| Tower Research Capital LLC (TRC) | 6,590 | $9.00K |